The U.S. Food and Drug Administration plans to have an expert panel review any Covid-19 vaccine application for emergency use, and wants to see at least two months of safety data, the agency said Tuesday.
The requirements will almost certainly add to the time it will take to review any vaccine, potentially past President
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.